vs
Side-by-side financial comparison of SIFCO INDUSTRIES INC (SIF) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
SIFCO INDUSTRIES INC is the larger business by last-quarter revenue ($24.0M vs $12.6M, roughly 1.9× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 7.5%, a 243.2% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 14.8%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 8.1%).
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
SIF vs SPRO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.0M | $12.6M |
| Net Profit | $1.8M | $31.5M |
| Gross Margin | 21.6% | — |
| Operating Margin | 10.7% | — |
| Net Margin | 7.5% | 250.7% |
| Revenue YoY | 14.8% | 24080.8% |
| Net Profit YoY | 177.3% | 250.9% |
| EPS (diluted) | $0.29 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.0M | $12.6M | ||
| Q3 25 | $22.8M | $0 | ||
| Q2 25 | $22.1M | $0 | ||
| Q1 25 | $19.0M | $12.0K | ||
| Q4 24 | $20.9M | $52.0K | ||
| Q3 24 | $21.7M | $65.0K | ||
| Q2 24 | $22.0M | $114.0K | ||
| Q1 24 | $20.5M | $140.0K |
| Q4 25 | $1.8M | $31.5M | ||
| Q3 25 | $-429.0K | $-7.4M | ||
| Q2 25 | $3.4M | $-1.7M | ||
| Q1 25 | $-1.4M | $-13.9M | ||
| Q4 24 | $-2.3M | — | ||
| Q3 24 | $-443.0K | $-17.1M | ||
| Q2 24 | $72.0K | $-17.9M | ||
| Q1 24 | $-1.6M | $-12.7M |
| Q4 25 | 21.6% | — | ||
| Q3 25 | 9.6% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 4.4% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | 12.3% | — | ||
| Q1 24 | 7.3% | — |
| Q4 25 | 10.7% | — | ||
| Q3 25 | -1.7% | — | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | -4.1% | -122758.3% | ||
| Q4 24 | -9.2% | — | ||
| Q3 24 | -1.5% | -28604.6% | ||
| Q2 24 | 0.7% | -16720.2% | ||
| Q1 24 | -6.5% | -9987.1% |
| Q4 25 | 7.5% | 250.7% | ||
| Q3 25 | -1.9% | — | ||
| Q2 25 | 15.4% | — | ||
| Q1 25 | -7.3% | -115550.0% | ||
| Q4 24 | -11.1% | — | ||
| Q3 24 | -2.0% | -26380.0% | ||
| Q2 24 | 0.3% | -15668.4% | ||
| Q1 24 | -7.8% | -9049.3% |
| Q4 25 | $0.29 | $0.56 | ||
| Q3 25 | $-0.07 | $-0.13 | ||
| Q2 25 | $0.56 | $-0.03 | ||
| Q1 25 | $-0.23 | $-0.25 | ||
| Q4 24 | $-0.38 | — | ||
| Q3 24 | $-0.07 | $-0.32 | ||
| Q2 24 | $0.01 | $-0.33 | ||
| Q1 24 | $-0.27 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1M | $40.3M |
| Total DebtLower is stronger | $39.0K | — |
| Stockholders' EquityBook value | $38.7M | $59.0M |
| Total Assets | $74.9M | $68.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1M | $40.3M | ||
| Q3 25 | $491.0K | $48.6M | ||
| Q2 25 | $2.0M | $31.2M | ||
| Q1 25 | $1.9M | $48.9M | ||
| Q4 24 | $3.1M | $52.9M | ||
| Q3 24 | $1.7M | $76.3M | ||
| Q2 24 | $3.4M | $63.5M | ||
| Q1 24 | $2.5M | $82.3M |
| Q4 25 | $39.0K | — | ||
| Q3 25 | $51.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $4.1M | — |
| Q4 25 | $38.7M | $59.0M | ||
| Q3 25 | $36.9M | $26.5M | ||
| Q2 25 | $35.8M | $32.8M | ||
| Q1 25 | $32.4M | $33.8M | ||
| Q4 24 | $33.7M | $46.1M | ||
| Q3 24 | $30.4M | $65.5M | ||
| Q2 24 | $29.8M | $80.5M | ||
| Q1 24 | $29.7M | $96.2M |
| Q4 25 | $74.9M | $68.9M | ||
| Q3 25 | $73.4M | $54.2M | ||
| Q2 25 | $77.3M | $62.1M | ||
| Q1 25 | $78.8M | $77.7M | ||
| Q4 24 | $81.0M | $110.5M | ||
| Q3 24 | $104.6M | $135.2M | ||
| Q2 24 | $106.3M | $149.9M | ||
| Q1 24 | $104.2M | $167.7M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.1M | $-8.4M |
| Free Cash FlowOCF − Capex | $8.0M | — |
| FCF MarginFCF / Revenue | 33.3% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | 4.51× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $11.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.1M | $-8.4M | ||
| Q3 25 | $726.0K | $17.4M | ||
| Q2 25 | $371.0K | $-17.7M | ||
| Q1 25 | $2.8M | $-4.0M | ||
| Q4 24 | $-3.8M | $-23.4M | ||
| Q3 24 | $857.0K | $12.8M | ||
| Q2 24 | $382.0K | $-18.7M | ||
| Q1 24 | $-3.2M | $5.9M |
| Q4 25 | $8.0M | — | ||
| Q3 25 | $566.0K | — | ||
| Q2 25 | $310.0K | — | ||
| Q1 25 | $2.7M | — | ||
| Q4 24 | $-3.9M | — | ||
| Q3 24 | $580.0K | — | ||
| Q2 24 | $-175.0K | — | ||
| Q1 24 | $-3.9M | — |
| Q4 25 | 33.3% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 14.1% | — | ||
| Q4 24 | -18.8% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | -0.8% | — | ||
| Q1 24 | -18.9% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.5% | — | ||
| Q1 24 | 3.3% | — |
| Q4 25 | 4.51× | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
SPRO
Segment breakdown not available.
